Peculiarities of influence of NO-synthase inhibitors on behavioral parameters of rats
- Authors: Bashkatova V.G.1, Bogdanova N.G.1, Alexeeva E.V.1, Nazarova G.A.1, Sudakov S.K.1
-
Affiliations:
- Anokhin Scientific Research Institute of Normal Physiology
- Issue: Vol 28, No 3 (2020)
- Pages: 275-282
- Section: Original study
- Submitted: 13.04.2020
- Accepted: 04.08.2020
- Published: 19.10.2020
- URL: https://journals.eco-vector.com/pavlovj/article/view/33427
- DOI: https://doi.org/10.23888/PAVLOVJ2020283275-282
- ID: 33427
Cite item
Abstract
Aim. A comparative study of the influence of nitric oxide synthase (NO-synthase) inhibitors on the parameters of anxiety, motor activity and pain sensitivity of rats.
Materials and Methods. The work was conducted on male rats of Wistar line. The anxiety level and locomotor activity of rats were studied in the «elevated plus maze» (EPM) test. Pain sensitivity of the animals was tested on the «hotplate» apparatus. In the work, selective inhibitor of inducible isoform of NO-synthase – aminoguanidine – at a dose of 50 mg/kg, and non-selective inhibitor of this enzyme – N-nitro-L-arginine – at a dose of 50 mg/kg, were used. Rats of the control group were introduced the equivalent quantity of normal saline.
NO-synthase inducible inhibitor – aminoguadinine did not produce any influence on the anxiety level, but led to reduction of the horizontal motor activity of rats. Introduction of non-selective NO-synthase inhibitor – N-nitro-L-arginine – was accompanied by reduction of the anxiety and of the locomotor activity of animals in the EPM test. Both investigated NO-synthase inhibitors induced alteration of pain sensitivity of rats in the form of hypoalgesia. Here, the most pronounced nociceptive effect was observed with introduction of non-selective NO-synthase inhibitor.
Conclusion. In the work the evidence of participation of inducible isoform of NO-synthase in realization of the motor activity and pain sensitivity processes in rats is shown. In result of the conducted experiments it was found that introduction of non-selective NO-synthase inhibitor N-nitro-L-arginine was accompanied by evident alterations of anxious behavior, locomotor activity and nociceptive sensitivity of rats. The results obtained confirm the important role of the system of regulation of nitric oxide synthesis in neurochemical mechanisms of behavioral reactions in rats.
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Valentina G. Bashkatova
Anokhin Scientific Research Institute of Normal Physiology
Author for correspondence.
Email: v.bashkatova@nphys.ru
ORCID iD: 0000-0001-6632-5973
SPIN-code: 7383-8483
PhD in Biological Sciences, Leading Researcher of the Reinforcements Physiology Laboratory
Russian Federation, MoscowNatalia G. Bogdanova
Anokhin Scientific Research Institute of Normal Physiology
Email: natbog07@yandex.ru
ORCID iD: 0000-0003-2345-8578
SPIN-code: 5580-9324
PhD in Biological Sciences, Senior Researcher of the Reinforcements Physiology Laboratory
Russian Federation, MoscowElena V. Alexeeva
Anokhin Scientific Research Institute of Normal Physiology
Email: pravo-nadzor@yandex.ru
ORCID iD: 0000-0001-8488-0508
SPIN-code: 9248-3657
Junior Researcher of the Reinforcements Physiology Laboratory
Russian Federation, MoscowGalina A. Nazarova
Anokhin Scientific Research Institute of Normal Physiology
Email: g-a-nazarova@rambler.ru
ORCID iD: 0000-0002-7470-1120
SPIN-code: 2506-4688
PhD in Biological Sciences, Senior Researcher of the Reinforcements Physiology Labo-ratory
Russian Federation, MoscowSergey K. Sudakov
Anokhin Scientific Research Institute of Normal Physiology
Email: s-sudakov@nphys.ru
ORCID iD: 0000-0002-9485-3439
SPIN-code: 1127-4090
MD, PhD, Professor, Corresponding Member of RAS, Deputy Director for Research, Head of the Reinforcements Physiology Laboratory
Russian Federation, MoscowReferences
- Moncada S, Bolaños JP. Nitric oxide, cell bioenergetics and neurodegeneration. Journal of Neurochemistry. 2006;97(6):1676-89. doi: 10.1111/j.1471 -4159.2006.03988.x
- Garthwaite J. NO as a multimodal transmitter in the brain: discovery and current status. British Journal of Pharmacology. 2019;176(2):197-211. doi:10.1111/ bph. 14532
- Philippu A. Nitric oxide: a universal modulator of brain function. Current Medicinal Chemistry. 2016;23(24): 2643-52. doi: 10.2174/0929867323666160627120408
- Kikuchi R, Ambe K, Kon H, et al. Nitric oxide synthase (NOS) isoform expression after peripheral nerve transec-tion in mice. The Bulletin of Tokyo Dental College. 2018;59(1):15-25. doi: 10.2209/tdc publication.2017-0007
- Fadyukova O.E., Kuzenkov V.S., Koshelev V.B., et al. Semax prevents from the excess nitric oxide production caused by incomplete global ischemia in rat brain. Eksperimental’naya i Klinicheskaya Far-makologiya. 2001;64(2):31-4. (In Russ).
- Sharma Sh, Puttachary S, Thippeswamy T. Glial source of nitric oxide in epileptogenesis: a target for disease modification in epilepsy. Journal of Neuroscience Research. 2019;97(11):1363-77. doi:10. 1002/jnr.24205
- Tripathy D, Chakraborty J, Mohanakumar KP. Antagonistic pleiotropic effects of nitric oxide in the pathophysi-ology of Parkinson's disease. Free Radical Research. 2015;49(9):1129-39. doi: 10.3109/10 715762.2015.1045505
- Gilhotra N, Jain H, Dhingra D. Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice. Indian Journal of Experimental Biology. 2010;48(4):365-72.
- Gulati K, Rai N, Ray A. Nitric oxide and anxiety. Vitamins and Hormones. 2017;103:169-92. doi:10. 1016/bs.vh.2016.09.001
- Kumar A, Chanana P. Role of nitric oxide in stress-induced anxiety: from pathophysiology to therapeutic target. Vitamins and Hormones. 2017;103:147-67. doi: 10.1016/bs.vh.2016.09.004
- Miclescu A, Gordh T. Nitric oxide and pain: 'So-mething old, something new'. Acta Anaesthesiolo-gica Scandi-navica. 2009;53(9):1107-20. doi:10.1111/ j.1399-76.2009.02054.x
- Pradhan AA, Bertels Z, Akerman S. Targeted Nitric Oxide Synthase Inhibitors for Migraine. Neuro-therapeutics. 2018;15:391-401. doi: 10.1007/s13311 -018-0614-7
- Camargo EA, Santana DG., Silva CI, et al. Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2. European Journal of Pain. 2014;18(5):691-700. doi:10.1002/ j.1532-2149.2013.00414.x
- Bashkatova V, Philippu A. Role of nitric oxide in psychostimulant-induced neurotoxicity. AIMS Neuroscience. 2019;6(3):191-3. doi: 10.3934/Neuroscience. 2019.3.191
- Pellow S, Chopin P, File E, et al. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods. 1985;14(3):149-67. doi:10.1016/ 0165-0270(85)90031-7
- Bondarenko DA, Dyachenko IA, Skobtsov DI, et al. In vivo models of studying of analgetic activity. Biomedi-cine. 2011;(2):84-94. (In Russ).
- Celik T, Zagli U, Kayir H, et al. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug and Alcohol Dependence. 1999; 56(2):109-13. doi: 10.1016/s0376-8716 (99)00031-9
- Joung HY, Jung EY, Kim K, et al. The differential role of NOS inhibitors on stress-induced anxiety and neuroen-docrine alterations in the rat. Beha-vioural Brain Research. 2012;235(2):176-81. doi:10. 1016/j.bbr.2012.07.037
- Cinelli MA, Do HT, Miley GP, et al. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Medic-inal Research Reviews. 2020;40(1): 158-89. doi: 10.1002/med.21599
Supplementary files
![](/img/style/loading.gif)